Revance Therapeutics, Inc. earnings per share and revenue

RVNC earnings per share for the last quarter are -0.50 USD whereas the estimation was -0.65 USD which accounts for 23.89% surprise. Company revenue for the same period amounts to 69.80 M USD despite the estimated figure of 62.12 M USD. Estimated earnings per share for the next quarter are -0.46 USD, and revenue is expected to reach 56.40 M USD. Also watch annual changes over time to get a bigger picture of RVNC earnings per share and revenue dynamics.